Medicure Inc. (MPH) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Medicare's Earnings Conference Call for the quarter ended December 30th, 2025. My name is Holly, and I will be your operator for today's call. At this time, all participants are in listen-only mode. Before we proceed, I would like to remind everyone that this presentation contains forward-looking statements relating to future results, events, and expectations, which are made pursuant to the Safe Harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, those described in the company's most recent annual information form and Form 20-F. Later, we will conduct a question-and-answer session. Please note that this conference call is being recorded and today's date is August 21st, 2025. I would like to turn the conference call over to Dr. Albert Friesen, Chief Executive Officer of Medicure, Inc. Please go ahead, Dr. Friesen. Thank you, Holly, and good morning to all on the call. We appreciate your interest and participation in today's call. Joining me today on the Q2-25 call is are Dr. Niels Owens, President and Chief Operating Officer, and Haris Uddin, Medicare's Chief Financial Officer. The net revenue for Q2 2025 was $6.7 million, an increase from the previous year, where the net revenue was $5.2 million. The company recorded a net loss of approximately $786,000, or $0.08 per share, compared to a net loss in the previous year of $1.1 million and 12 cents per share. The non-cash items contributing to the loss include amortization, stock options, et cetera, about the same as the net loss. And in addition, Me...